Cargando…

Chloroquine as a prophylactic agent against COVID-19?

• Efficacy of chloroquine and hydroxychloroquine in COVID-19 treatment is discussed. • Prophylactic use of chloroquine or hydroxychloroquine in COVID-19 is considered.

Detalles Bibliográficos
Autores principales:	Gendrot, Mathieu, Javelle, Emilie, Clerc, Axelle, Savini, Hélène, Pradines, Bruno
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier B.V. and International Society of Chemotherapy. 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7152897/ https://www.ncbi.nlm.nih.gov/pubmed/32294495 http://dx.doi.org/10.1016/j.ijantimicag.2020.105980

Ejemplares similares

Prevalence of mutations in the Plasmodium falciparum chloroquine resistance transporter, PfCRT, and association with ex vivo susceptibility to common anti-malarial drugs against African Plasmodium falciparum isolates
por: Foguim, Francis Tsombeng, et al.
Publicado: (2020)

Methylene Blue-Based Combination Therapy with Amodiaquine Prevents Severe Malaria in an Experimental Rodent Model
por: Dormoi, Jérôme, et al.
Publicado: (2022)

Prophylactic (hydroxy)chloroquine in COVID-19: Potential relevance for cardiac arrhythmia risk
por: Offerhaus, Joost A., et al.
Publicado: (2020)

In vitro interaction of lumefantrine and piperaquine by atorvastatin against Plasmodium falciparum
por: Dormoi, Jérome, et al.
Publicado: (2014)

Chloroquine and hydroxychloroquine as a repurposed agent against COVID-19: a narrative review
por: Acharya, Yogesh, et al.
Publicado: (2020)

Are k13 and plasmepsin II genes, involved in Plasmodium falciparum resistance to artemisinin derivatives and piperaquine in Southeast Asia, reliable to monitor resistance surveillance in Africa?
por: Foguim Tsombeng, Francis, et al.
Publicado: (2019)

Prevalence of Mutations in the pfcoronin Gene and Association with Ex Vivo Susceptibility to Common Quinoline Drugs against Plasmodium falciparum
por: Delandre, Océane, et al.
Publicado: (2021)

Mutagenic, Genotoxic and Immunomodulatory effects of Hydroxychloroquine and Chloroquine: a review to evaluate its potential to use as a prophylactic drug against COVID-19
por: Giri, Allan, et al.
Publicado: (2020)

Comparative Assessment of the Sensitivity of Ten Commercial Rapid Diagnostic Test Kits for the Detection of Plasmodium
por: Gendrot, Mathieu, et al.
Publicado: (2022)

Of chloroquine and COVID-19
por: Touret, Franck, et al.
Publicado: (2020)

Failure of dihydroartemisinin plus piperaquine treatment of falciparum malaria by under-dosing in an overweight patient
por: Roseau, Jean Baptiste, et al.
Publicado: (2016)

Analysis of trapped mosquito excreta as a noninvasive method to reveal biodiversity and arbovirus circulation
por: L'Ambert, Grégory, et al.
Publicado: (2022)

COVID-19 pandemic more than a century after the Spanish flu
por: Javelle, Emilie, et al.
Publicado: (2021)

Primum non nocere – Are chloroquine and hydroxychloroquine safe prophylactic/treatment options for SARS-CoV-2 (covid-19)?
por: Biguetti, Claudia, et al.
Publicado: (2020)

Janus sword actions of chloroquine and hydroxychloroquine against COVID-19
por: Chen, Xuesong, et al.
Publicado: (2020)

Insights from nanomedicine into chloroquine efficacy against COVID-19
por: Hu, Tony Y., et al.
Publicado: (2020)

Monkeypox clinical disease: Literature review and a tool proposal for the monitoring of cases and contacts
por: Javelle, Emilie, et al.
Publicado: (2023)

A single dose of in situ gel formulation of antimalarial drug chloroquine phosphate as a sustained prophylactic candidate for COVID-19
por: Zelai, Noha Talal
Publicado: (2021)

Metal-chloroquine derivatives as possible anti-malarial drugs: evaluation of anti-malarial activity and mode of action
por: Navarro, Maribel, et al.
Publicado: (2014)

Chloroquine for COVID-19 Infection
por: Moore, Nicholas
Publicado: (2020)

Chloroquine, hydroxychloroquine and COVID-19
por: Erickson, T. B., et al.
Publicado: (2020)

Combating COVID-19 with Chloroquine
por: Hong, Wanjin
Publicado: (2020)

Treating COVID-19 with Chloroquine
por: Huang, Mingxing, et al.
Publicado: (2020)

Antimalarial chloroquine metamorphosed into antiviral agent against HIV with four modes of actions
por: Chandramohan, M, et al.
Publicado: (2012)

Plasmodium ovale wallikeri and P. ovale curtisi Infections and Diagnostic Approaches to Imported Malaria, France, 2013–2018
por: Joste, Valentin, et al.
Publicado: (2021)

Aminoquinolines against coronavirus disease 2019 (COVID-19): chloroquine or hydroxychloroquine
por: Sahraei, Zahra, et al.
Publicado: (2020)

Repositioning chloroquine as antiviral prophylaxis against COVID-19: potential and challenges
por: Chang, Raymond, et al.
Publicado: (2020)

In Vitro Evaluation of the Antiviral Activity of Methylene Blue Alone or in Combination against SARS-CoV-2
por: Gendrot, Mathieu, et al.
Publicado: (2021)

Antiviral Activity of Repurposing Ivermectin against a Panel of 30 Clinical SARS-CoV-2 Strains Belonging to 14 Variants
por: Delandre, Océane, et al.
Publicado: (2022)

The D113N mutation in the RING E3 ubiquitin protein ligase gene is not associated with ex vivo susceptibility to common anti-malarial drugs in African Plasmodium falciparum isolates
por: Gendrot, Mathieu, et al.
Publicado: (2018)

The Plasmodium falciparum chloroquine resistance transporter is associated with the ex vivo P. falciparum African parasite response to pyronaridine
por: Madamet, Marylin, et al.
Publicado: (2016)

Copper (I)-Chloroquine Complexes: Interactions with DNA and Ferriprotoporphyrin, Inhibition of β-Hematin Formation and Relation to Antimalarial Activity
por: Villarreal, Wilmer, et al.
Publicado: (2022)

Primaquine and Chloroquine Fumardiamides as Promising Antiplasmodial Agents
por: Beus, Maja, et al.
Publicado: (2019)

In vitro piperaquine susceptibility is not associated with the Plasmodium falciparum chloroquine resistance transporter gene
por: Pascual, Aurélie, et al.
Publicado: (2013)

Cytotoxic and Anti-Plasmodial Activities of Stephania dielsiana Y.C. Wu Extracts and the Isolated Compounds
por: Knockleby, James, et al.
Publicado: (2020)

Chloroquine and hydroxychloroquine in the context of COVID-19
por: Shukla, Ashutosh M, et al.
Publicado: (2020)

Chloroquine or hydroxychloroquine for prophylaxis of COVID-19
por: Principi, Nicola, et al.
Publicado: (2020)

Antimalarial artemisinin-based combination therapies (ACT) and COVID-19 in Africa: In vitro inhibition of SARS-CoV-2 replication by mefloquine-artesunate
por: Gendrot, Mathieu, et al.
Publicado: (2020)

Zinc(II)—The Overlooked Éminence Grise of Chloroquine’s Fight against COVID-19?
por: Hecel, Aleksandra, et al.
Publicado: (2020)

In Vitro Antiviral Activity of Doxycycline against SARS-CoV-2
por: Gendrot, Mathieu, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_hkgkh325k6kcjqlot4vjmrqvpq